|
1
|
Liu P, Pu J, Zhang J, Chen Z, Wei K and
Shi L: Bioinformatic analysis of miR-4792 regulates Radix
Tetrastigma hemsleyani flavone to inhibit proliferation, invasion,
and induce apoptosis of A549 cells. Onco Targets Ther.
12:1401–1412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pope CA III, Burnett RT, Thun MJ, Calle
EE, Krewski D, Ito K and Thurston GD: Lung cancer, cardiopulmonary
mortality, and long-term exposure to fine particulate air
pollution. JAMA. 287:1132–1141. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sui A, Zhang X and Zhu Q: Diagnostic value
of serum miR197 and miR145 in non-small cell lung cancer. Oncol
Lett. 17:3247–3252. 2019.PubMed/NCBI
|
|
4
|
Lynch TJ, Bell DW, Sordella R,
Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat
SM, Supko JG, Haluska FG, et al: Activating mutations in the
epidermal growth factor receptor underlying responsiveness of
non-small-cell lung cancer to gefitinib. N Engl J Med.
350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carvalho PE, Antonãngelo L, Bernardi FD,
Leão LE, Rodrigues OR and Capelozzi VL: Useful prognostic panel
markers to express the biological tumor status in resected lung
adenocarcinomas. Jpn J Clin Oncol. 30:478–486. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dews M, Homayouni A, Yu D, Murphy D,
Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT and
Thomas-Tikhonenko A: Augmentation of tumor angiogenesis by a
Myc-activated microRNA cluster. Nat Genet. 38:1060–1065. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitra R, Edmonds MD, Sun J, Zhao M, Yu H,
Eischen CM and Zhao Z: Reproducible combinatorial regulatory
networks elucidate novel oncogenic microRNAs in non-small cell lung
cancer. RNA. 20:1356–1368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wozniak MB, Scelo G, Muller DC, Mukeria A,
Zaridze D and Brennan P: Circulating microRNAs as non-invasive
biomarkers for early detection of non-small-cell lung cancer. PLoS
One. 10:e01250262015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao Q, Zhang AM, Ma H, Lin S, Wang XX, Sun
JG and Chen ZT: Novel molecular beacons to monitor microRNAs in
non-small-cell lung cancer. Mol Cell Probes. 26:182–187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goga A and Benz C: Anti-oncomir
suppression of tumor phenotypes. Mol Interv. 7:199–202, 180. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan X, Zhu Z, Xu S, Yang LN, Liao XH,
Zheng M, Yang D, Wang J, Chen D, Wang L, et al: MicroRNA-140-5p
inhibits hepatocellular carcinoma by directly targeting the unique
isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep.
7:459152017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou CW, Zhao WJ, Zhu YG and Zhao XD:
MiR-185 inhibits tumor growth and enhances chemo-resistance via
targeting SRY-related high mobility group box transcription factor
13 in non-small-cell carcinoma. Am J Transl Res. 10:2600–2609.
2018.PubMed/NCBI
|
|
19
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang W, Zou C, Pan L, Xu Y, Qi W, Ma G,
Hou Y and Jiang P: MicroRNA-140-5p inhibits the progression of
colorectal cancer by targeting VEGFA. Cell Physiol Biochem.
37:1123–1133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong C, Liu X, Wang H, Li J, Dai L, Li J
and Xu Z: Hypoxic non-small-cell lung cancer cell-derived exosomal
miR-21 promotes resistance of normoxic cell to cisplatin. Onco
Targets Ther. 12:1947–1956. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Flamini V, Jiang WG and Cui Y: Therapeutic
Role of MiR-140-5p for the treatment of non-small cell lung cancer.
Anticancer Res. 37:4319–4327. 2017.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arcà B, Colantoni A, Fiorillo C, Severini
F, Benes V, Di Luca M, Calogero RA and Lombardo F: MicroRNAs from
saliva of anopheline mosquitoes mimic human endogenous miRNAs and
may contribute to vector-host-pathogen interactions. Sci Rep.
9:29552019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mirzaei H, Khataminfar S, Mohammadparast
S, Sales SS, Maftouh M, Mohammadi M, Simonian M, Parizadeh SM,
Hassanian SM and Avan A: Circulating microRNAs as potential
diagnostic biomarkers and therapeutic targets in gastric cancer:
Current status and future perspectives. Curr Med Chem.
23:4135–4150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Long XB, Sun GB, Hu S, Liang GT, Wang N,
Zhang XH, Cao PP, Zhen HT, Cui YH and Liu Z: Let-7a microRNA
functions as a potential tumor suppressor in human laryngeal
cancer. Oncol Rep. 22:1189–1195. 2009.PubMed/NCBI
|
|
27
|
Cheng TF, Choudhuri S and Muldoon-Jacobs
K: Epigenetic targets of some toxicologically relevant metals: A
review of the literature. J Appl Toxicol. 32:643–653. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang K, Chen M and Wu W: Analysis of
microRNA (miRNA) expression profiles reveals 11 key biomarkers
associated with non-small cell lung cancer. World J Surg Oncol.
15:1752017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y,
Li Y, Wu Q and Deng Y: Integrative microRNA and gene profiling data
analysis reveals novel biomarkers and mechanisms for lung cancer.
Oncotarget. 7:8441–8454. 2016.PubMed/NCBI
|
|
30
|
Xiao X, Mruk DD, Lee WM and Cheng CY:
c-Yes regulates cell adhesion at the blood-testis barrier and the
apical ectoplasmic specialization in the seminiferous epithelium of
rat testes. Int J Biochem Cell Biol. 43:651–665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bilal E, Alexe G, Yao M, Cong L, Kulkarni
A, Ginjala V, Toppmeyer D, Ganesan S and Bhanot G: Identification
of the YES1 kinase as a therapeutic target in basal-like breast
cancers. Genes Cancer. 1:1063–1073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seki T, Fujii G, Mori S, Tamaoki N and
Shibuya M: Amplification of c-yes-1 proto-oncogene in a primary
human gastric cancer. Jpn J Cancer Res. 76:907–910. 1985.PubMed/NCBI
|
|
33
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee SA, Kim JS, Park SY, Kim HJ, Yu SK,
Kim CS, Chun HS, Kim J, Park JT, Go D and Kim DK: miR-203
downregulates Yes-1 and suppresses oncogenic activity in human oral
cancer cells. J Biosci Bioeng. 120:351–358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y,
Zhang T, Khaliq J and Li Y: miR-140-5p suppresses the
proliferation, migration and invasion of gastric cancer by
regulating YES1. Mol Cancer. 16:1392017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mohamed MS, Bishr MK, Almutairi FM and Ali
AG: Inhibitors of apoptosis: Clinical implications in cancer.
Apoptosis. 22:1487–1509. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Warren CFA, Wong-Brown MW and Bowden NA:
BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis.
10:1772019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Julien O and Wells JA: Caspases and their
substrates. Cell Death Differ. 24:1380–1389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Adams CM, Clark-Garvey S, Porcu P and
Eischen CM: Targeting the Bcl-2 family in B cell lymphoma. Front
Oncol. 8:6362019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin L, Cheng K, Xie Z, Chen C, Chen L,
Huang Y and Liang Z: Purification and characterization a
polysaccharide from Hedyotis diffusa and its apoptosis inducing
activity toward human lung cancer cell line A549. Int J Biol
Macromol. 122:64–71. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu P, Cai X, Zhang W, Li Y, Qiu P, Lu D
and He X: Flavonoids of Rosa roxburghii Tratt exhibit
radioprotection and anti-apoptosis properties via the
Bcl-2(Ca(2+))/Caspase-3/PARP-1 pathway. Apoptosis. 21:1125–1143.
2016. View Article : Google Scholar : PubMed/NCBI
|
